Clinical Trials Directory

Trials / Conditions / FLT3-TKD Mutation

FLT3-TKD Mutation

4 registered clinical trials studyying FLT3-TKD Mutation — 1 currently recruiting.

StatusTrialSponsorPhase
RecruitingStudy Investigating the Efficacy and Safety of the Addition of Oral-azacitidine to Salvage Treatment by Gilter
NCT06022003
French Innovative Leukemia OrganisationPhase 2
CompletedA Non-interventional Ambispective Real-world Cohort of rEfractory and reLapsed (R/R) FLT3 Mutated Acute MyEloi
NCT05193448
French Innovative Leukemia Organisation—
UnknownItalian Non-Interventional Study of FLT3 Mutated AML Patients
NCT03547258
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS—
AvailableIndividual Patient Compassionate Use of Crenolanib
NCT03620318
Arog Pharmaceuticals, Inc.—